Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
EXOSC9 encodes a component of the human exosome, a exoribonuclease complex which processes and degrades RNA in the nucleus and cytoplasm. Additionally we are shipping EXOSC9 Proteins (11) and EXOSC9 Kits (1) and many more products for this protein.
Showing 10 out of 46 products:
Chicken Polyclonal EXOSC9 Primary Antibody for ChIP, ICC - ABIN4309778
McIver, Katsumura, Davids, Liu, Kang, Yang, Bresnick: Exosome complex orchestrates developmental signaling to balance proliferation and differentiation during erythropoiesis. in eLife 2016
Show all 3 references for ABIN4309778
Human Polyclonal EXOSC9 Primary Antibody for WB - ABIN375039
Schilders, Raijmakers, Malmegrim, Vande Walle, Saelens, Vree Egberts, van Venrooij, Vandenabeele, Pruijn: Caspase-mediated cleavage of the exosome subunit PM/Scl-75 during apoptosis. in Arthritis research & therapy 2007
inactivation of both exosc9, which encodes a component of the RNA exosome, and ptbp1, which encodes an RNA-binding protein abundant in Xenopus embryonic skin, impairs embryonic Xenopus skin development.
Although not required for exosome stability, PM/Scl-100 (show EXOSC10 Antibodies) and PM/Scl-75 are involved in mRNA degradation.
Protein-protein interactions between human exosome components support the assembly of RNase PH-type subunits into a six-membered PNPase (show PNPT1 Antibodies)-like ring.
The association of the human PM/Scl-75 autoantigen with the exosome is dependent on a newly identified N terminus.
The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements, possibly by direct binding of PM/Scl-75 to these RNA regions.
PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome.
This gene encodes a component of the human exosome, a exoribonuclease complex which processes and degrades RNA in the nucleus and cytoplasm. This component may play a role in mRNA degradation and the polymyositis/scleroderma autoantigen complex. Alternative splicing results in multiple transcript variants.
, exosome complex exonuclease RRP45
, exosome component 9
, exosome complex exonuclease RRP45-like
, polymyositis/scleroderma autoantigen 1
, P75 polymyositis-scleroderma overlap syndrome associated autoantigen
, P75 polymyositis-scleroderma overlap syndrome-associated autoantigen
, PMSCL autoantigen, 75kD
, autoantigen PM/Scl 1
, exosome complex component RRP45
, polymyositis/scleroderma autoantigen 1, 75kDa
, polymyositis/scleroderma autoantigen 75 kDa